1 Ketorolac Tromethamine Market Overview 1.1 Product Overview and Scope of Ketorolac Tromethamine 1.2 Ketorolac Tromethamine Segment by Type 1.2.1 Global Ketorolac Tromethamine Sales Growth Rate Comparison by Type (2022-2028) 1.2.2 Injection 1.2.3 Ophthalmic 1.2.4 Nasal 1.2.5 Oral tablet 1.3 Ketorolac Tromethamine Segment by Application 1.3.1 Global Ketorolac Tromethamine Sales Comparison by Application: (2022-2028) 1.3.2 Short-term treatment of pain 1.3.3 Ophthalmic Surgery 1.4 Global Ketorolac Tromethamine Market Size Estimates and Forecasts 1.4.1 Global Ketorolac Tromethamine Revenue 2017-2028 1.4.2 Global Ketorolac Tromethamine Sales 2017-2028 1.4.3 Ketorolac Tromethamine Market Size by Region: 2017 Versus 2021 Versus 2028 2 Ketorolac Tromethamine Market Competition by Manufacturers 2.1 Global Ketorolac Tromethamine Sales Market Share by Manufacturers (2017-2022) 2.2 Global Ketorolac Tromethamine Revenue Market Share by Manufacturers (2017-2022) 2.3 Global Ketorolac Tromethamine Average Price by Manufacturers (2017-2022) 2.4 Manufacturers Ketorolac Tromethamine Manufacturing Sites, Area Served, Product Type 2.5 Ketorolac Tromethamine Market Competitive Situation and Trends 2.5.1 Ketorolac Tromethamine Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Ketorolac Tromethamine Players Market Share by Revenue 2.5.3 Global Ketorolac Tromethamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Ketorolac Tromethamine Retrospective Market Scenario by Region 3.1 Global Ketorolac Tromethamine Retrospective Market Scenario in Sales by Region: 2017-2022 3.2 Global Ketorolac Tromethamine Retrospective Market Scenario in Revenue by Region: 2017-2022 3.3 North America Ketorolac Tromethamine Market Facts & Figures by Country 3.3.1 North America Ketorolac Tromethamine Sales by Country 3.3.2 North America Ketorolac Tromethamine Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Ketorolac Tromethamine Market Facts & Figures by Country 3.4.1 Europe Ketorolac Tromethamine Sales by Country 3.4.2 Europe Ketorolac Tromethamine Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Ketorolac Tromethamine Market Facts & Figures by Region 3.5.1 Asia Pacific Ketorolac Tromethamine Sales by Region 3.5.2 Asia Pacific Ketorolac Tromethamine Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Ketorolac Tromethamine Market Facts & Figures by Country 3.6.1 Latin America Ketorolac Tromethamine Sales by Country 3.6.2 Latin America Ketorolac Tromethamine Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Ketorolac Tromethamine Market Facts & Figures by Country 3.7.1 Middle East and Africa Ketorolac Tromethamine Sales by Country 3.7.2 Middle East and Africa Ketorolac Tromethamine Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Ketorolac Tromethamine Historic Market Analysis by Type 4.1 Global Ketorolac Tromethamine Sales Market Share by Type (2017-2022) 4.2 Global Ketorolac Tromethamine Revenue Market Share by Type (2017-2022) 4.3 Global Ketorolac Tromethamine Price by Type (2017-2022) 5 Global Ketorolac Tromethamine Historic Market Analysis by Application 5.1 Global Ketorolac Tromethamine Sales Market Share by Application (2017-2022) 5.2 Global Ketorolac Tromethamine Revenue Market Share by Application (2017-2022) 5.3 Global Ketorolac Tromethamine Price by Application (2017-2022) 6 Key Companies Profiled 6.1 Pfizer 6.1.1 Pfizer Corporation Information 6.1.2 Pfizer Description and Business Overview 6.1.3 Pfizer Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022) 6.1.4 Pfizer Ketorolac Tromethamine Product Portfolio 6.1.5 Pfizer Recent Developments/Updates 6.2 Omeros Corporation 6.2.1 Omeros Corporation Corporation Information 6.2.2 Omeros Corporation Description and Business Overview 6.2.3 Omeros Corporation Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022) 6.2.4 Omeros Corporation Ketorolac Tromethamine Product Portfolio 6.2.5 Omeros Corporation Recent Developments/Updates 6.3 Egalet US Inc. 6.3.1 Egalet US Inc. Corporation Information 6.3.2 Egalet US Inc. Description and Business Overview 6.3.3 Egalet US Inc. Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022) 6.3.4 Egalet US Inc. Ketorolac Tromethamine Product Portfolio 6.3.5 Egalet US Inc. Recent Developments/Updates 6.4 Allergan 6.4.1 Allergan Corporation Information 6.4.2 Allergan Description and Business Overview 6.4.3 Allergan Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Allergan Ketorolac Tromethamine Product Portfolio 6.4.5 Allergan Recent Developments/Updates 6.5 Dr. Reddy’s Laboratories 6.5.1 Dr. Reddy’s Laboratories Corporation Information 6.5.2 Dr. Reddy’s Laboratories Description and Business Overview 6.5.3 Dr. Reddy’s Laboratories Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022) 6.5.4 Dr. Reddy’s Laboratories Ketorolac Tromethamine Product Portfolio 6.5.5 Dr. Reddy’s Laboratories Recent Developments/Updates 6.6 Teva 6.6.1 Teva Corporation Information 6.6.2 Teva Description and Business Overview 6.6.3 Teva Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022) 6.6.4 Teva Ketorolac Tromethamine Product Portfolio 6.6.5 Teva Recent Developments/Updates 6.7 Mylan 6.6.1 Mylan Corporation Information 6.6.2 Mylan Description and Business Overview 6.6.3 Mylan Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Mylan Ketorolac Tromethamine Product Portfolio 6.7.5 Mylan Recent Developments/Updates 6.8 West Ward Pharmaceuticals 6.8.1 West Ward Pharmaceuticals Corporation Information 6.8.2 West Ward Pharmaceuticals Description and Business Overview 6.8.3 West Ward Pharmaceuticals Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022) 6.8.4 West Ward Pharmaceuticals Ketorolac Tromethamine Product Portfolio 6.8.5 West Ward Pharmaceuticals Recent Developments/Updates 6.9 Fresenius Kabi 6.9.1 Fresenius Kabi Corporation Information 6.9.2 Fresenius Kabi Description and Business Overview 6.9.3 Fresenius Kabi Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022) 6.9.4 Fresenius Kabi Ketorolac Tromethamine Product Portfolio 6.9.5 Fresenius Kabi Recent Developments/Updates 6.10 Apotex 6.10.1 Apotex Corporation Information 6.10.2 Apotex Description and Business Overview 6.10.3 Apotex Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022) 6.10.4 Apotex Ketorolac Tromethamine Product Portfolio 6.10.5 Apotex Recent Developments/Updates 6.11 Sandoz 6.11.1 Sandoz Corporation Information 6.11.2 Sandoz Ketorolac Tromethamine Description and Business Overview 6.11.3 Sandoz Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022) 6.11.4 Sandoz Ketorolac Tromethamine Product Portfolio 6.11.5 Sandoz Recent Developments/Updates 6.12 Amphastar Pharmaceuticals 6.12.1 Amphastar Pharmaceuticals Corporation Information 6.12.2 Amphastar Pharmaceuticals Ketorolac Tromethamine Description and Business Overview 6.12.3 Amphastar Pharmaceuticals Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022) 6.12.4 Amphastar Pharmaceuticals Ketorolac Tromethamine Product Portfolio 6.12.5 Amphastar Pharmaceuticals Recent Developments/Updates 6.13 Gland Pharma Limited 6.13.1 Gland Pharma Limited Corporation Information 6.13.2 Gland Pharma Limited Ketorolac Tromethamine Description and Business Overview 6.13.3 Gland Pharma Limited Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022) 6.13.4 Gland Pharma Limited Ketorolac Tromethamine Product Portfolio 6.13.5 Gland Pharma Limited Recent Developments/Updates 6.14 Akorn 6.14.1 Akorn Corporation Information 6.14.2 Akorn Ketorolac Tromethamine Description and Business Overview 6.14.3 Akorn Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022) 6.14.4 Akorn Ketorolac Tromethamine Product Portfolio 6.14.5 Akorn Recent Developments/Updates 6.15 Sun Pharmaceutical 6.15.1 Sun Pharmaceutical Corporation Information 6.15.2 Sun Pharmaceutical Ketorolac Tromethamine Description and Business Overview 6.15.3 Sun Pharmaceutical Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022) 6.15.4 Sun Pharmaceutical Ketorolac Tromethamine Product Portfolio 6.15.5 Sun Pharmaceutical Recent Developments/Updates 6.16 Sagent Pharmaceuticals 6.16.1 Sagent Pharmaceuticals Corporation Information 6.16.2 Sagent Pharmaceuticals Ketorolac Tromethamine Description and Business Overview 6.16.3 Sagent Pharmaceuticals Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022) 6.16.4 Sagent Pharmaceuticals Ketorolac Tromethamine Product Portfolio 6.16.5 Sagent Pharmaceuticals Recent Developments/Updates 6.17 Aurobindo Pharma 6.17.1 Aurobindo Pharma Corporation Information 6.17.2 Aurobindo Pharma Ketorolac Tromethamine Description and Business Overview 6.17.3 Aurobindo Pharma Ketorolac Tromethamine Sales, Revenue and Gross Margin (2017-2022) 6.17.4 Aurobindo Pharma Ketorolac Tromethamine Product Portfolio 6.17.5 Aurobindo Pharma Recent Developments/Updates 7 Ketorolac Tromethamine Manufacturing Cost Analysis 7.1 Ketorolac Tromethamine Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Ketorolac Tromethamine 7.4 Ketorolac Tromethamine Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Ketorolac Tromethamine Distributors List 8.3 Ketorolac Tromethamine Customers 9 Ketorolac Tromethamine Market Dynamics 9.1 Ketorolac Tromethamine Industry Trends 9.2 Ketorolac Tromethamine Market Drivers 9.3 Ketorolac Tromethamine Market Challenges 9.4 Ketorolac Tromethamine Market Restraints 10 Global Market Forecast 10.1 Ketorolac Tromethamine Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Ketorolac Tromethamine by Type (2023-2028) 10.1.2 Global Forecasted Revenue of Ketorolac Tromethamine by Type (2023-2028) 10.2 Ketorolac Tromethamine Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Ketorolac Tromethamine by Application (2023-2028) 10.2.2 Global Forecasted Revenue of Ketorolac Tromethamine by Application (2023-2028) 10.3 Ketorolac Tromethamine Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Ketorolac Tromethamine by Region (2023-2028) 10.3.2 Global Forecasted Revenue of Ketorolac Tromethamine by Region (2023-2028) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Ketorolac Tromethamine Sales Growth Rate Comparison by Type (2022-2028) & (K Units) & (US$ Million) Table 2. Global Ketorolac Tromethamine Sales Growth Rate Comparison by Application (2022-2028) & (K Units) & (US$ Million) Table 3. Global Ketorolac Tromethamine Market Size by Region (US$ Million) (2017 VS 2021 VS 2028) Table 4. Global Ketorolac Tromethamine Market Competitive Situation by Manufacturers in 2021 Table 5. Global Ketorolac Tromethamine Sales (K Units) of Key Manufacturers (2017-2022) Table 6. Global Ketorolac Tromethamine Sales Market Share by Manufacturers (2017-2022) Table 7. Global Ketorolac Tromethamine Revenue (US$ Million) by Manufacturers (2017-2022) Table 8. Global Ketorolac Tromethamine Revenue Share by Manufacturers (2017-2022) Table 9. Global Market Ketorolac Tromethamine Average Price (USD/Unit) of Key Manufacturers (2017-2022) Table 10. Manufacturers Ketorolac Tromethamine Manufacturing Sites and Area Served Table 11. Manufacturers Ketorolac Tromethamine Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Ketorolac Tromethamine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Ketorolac Tromethamine as of 2021) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Ketorolac Tromethamine Sales by Region (2017-2022) & (K Units) Table 16. Global Ketorolac Tromethamine Sales Market Share by Region (2017-2022) Table 17. Global Ketorolac Tromethamine Revenue by Region (2017-2022) & (US$ Million) Table 18. Global Ketorolac Tromethamine Revenue Market Share by Region (2017-2022) Table 19. North America Ketorolac Tromethamine Sales by Country (2017-2022) & (K Units) Table 20. North America Ketorolac Tromethamine Sales Market Share by Country (2017-2022) Table 21. North America Ketorolac Tromethamine Revenue by Country (2017-2022) & (US$ Million) Table 22. North America Ketorolac Tromethamine Revenue Market Share by Country (2017-2022) Table 23. Europe Ketorolac Tromethamine Sales by Country (2017-2022) & (K Units) Table 24. Europe Ketorolac Tromethamine Sales Market Share by Country (2017-2022) Table 25. Europe Ketorolac Tromethamine Revenue by Country (2017-2022) & (US$ Million) Table 26. Europe Ketorolac Tromethamine Revenue Market Share by Country (2017-2022) Table 27. Asia Pacific Ketorolac Tromethamine Sales by Region (2017-2022) & (K Units) Table 28. Asia Pacific Ketorolac Tromethamine Sales Market Share by Region (2017-2022) Table 29. Asia Pacific Ketorolac Tromethamine Revenue by Region (2017-2022) & (US$ Million) Table 30. Asia Pacific Ketorolac Tromethamine Revenue Market Share by Region (2017-2022) Table 31. Latin America Ketorolac Tromethamine Sales by Country (2017-2022) & (K Units) Table 32. Latin America Ketorolac Tromethamine Sales Market Share by Country (2017-2022) Table 33. Latin America Ketorolac Tromethamine Revenue by Country (2017-2022) & (US$ Million) Table 34. Latin America Ketorolac Tromethamine Revenue Market Share by Country (2017-2022) Table 35. Middle East and Africa Ketorolac Tromethamine Sales by Country (2017-2022) & (K Units) Table 36. Middle East and Africa Ketorolac Tromethamine Sales Market Share by Country (2017-2022) Table 37. Middle East and Africa Ketorolac Tromethamine Revenue by Country (2017-2022) & (US$ Million) Table 38. Middle East and Africa Ketorolac Tromethamine Revenue Market Share by Country (2017-2022) Table 39. Global Ketorolac Tromethamine Sales by Type (2017-2022) & (K Units) Table 40. Global Ketorolac Tromethamine Sales Market Share by Type (2017-2022) Table 41. Global Ketorolac Tromethamine Revenue by Type (2017-2022) & (US$ Million) Table 42. Global Ketorolac Tromethamine Revenue Share by Type (2017-2022) Table 43. Global Ketorolac Tromethamine Price by Type (2017-2022) & (USD/Unit) Table 44. Global Ketorolac Tromethamine Sales (K Units) by Application (2017-2022) Table 45. Global Ketorolac Tromethamine Sales Market Share by Application (2017-2022) Table 46. Global Ketorolac Tromethamine Revenue by Application (2017-2022) & (US$ Million) Table 47. Global Ketorolac Tromethamine Revenue Share by Application (2017-2022) Table 48. Global Ketorolac Tromethamine Price by Application (2017-2022) & (USD/Unit) Table 49. Pfizer Corporation Information Table 50. Pfizer Description and Business Overview Table 51. Pfizer Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 52. Pfizer Ketorolac Tromethamine Product Table 53. Pfizer Recent Developments/Updates Table 54. Omeros Corporation Corporation Information Table 55. Omeros Corporation Description and Business Overview Table 56. Omeros Corporation Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 57. Omeros Corporation Ketorolac Tromethamine Product Table 58. Omeros Corporation Recent Developments/Updates Table 59. Egalet US Inc. Corporation Information Table 60. Egalet US Inc. Description and Business Overview Table 61. Egalet US Inc. Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 62. Egalet US Inc. Ketorolac Tromethamine Product Table 63. Egalet US Inc. Recent Developments/Updates Table 64. Allergan Corporation Information Table 65. Allergan Description and Business Overview Table 66. Allergan Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 67. Allergan Ketorolac Tromethamine Product Table 68. Allergan Recent Developments/Updates Table 69. Dr. Reddy’s Laboratories Corporation Information Table 70. Dr. Reddy’s Laboratories Description and Business Overview Table 71. Dr. Reddy’s Laboratories Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 72. Dr. Reddy’s Laboratories Ketorolac Tromethamine Product Table 73. Dr. Reddy’s Laboratories Recent Developments/Updates Table 74. Teva Corporation Information Table 75. Teva Description and Business Overview Table 76. Teva Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 77. Teva Ketorolac Tromethamine Product Table 78. Teva Recent Developments/Updates Table 79. Mylan Corporation Information Table 80. Mylan Description and Business Overview Table 81. Mylan Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 82. Mylan Ketorolac Tromethamine Product Table 83. Mylan Recent Developments/Updates Table 84. West Ward Pharmaceuticals Corporation Information Table 85. West Ward Pharmaceuticals Description and Business Overview Table 86. West Ward Pharmaceuticals Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 87. West Ward Pharmaceuticals Ketorolac Tromethamine Product Table 88. West Ward Pharmaceuticals Recent Developments/Updates Table 89. Fresenius Kabi Corporation Information Table 90. Fresenius Kabi Description and Business Overview Table 91. Fresenius Kabi Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 92. Fresenius Kabi Ketorolac Tromethamine Product Table 93. Fresenius Kabi Recent Developments/Updates Table 94. Apotex Corporation Information Table 95. Apotex Description and Business Overview Table 96. Apotex Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 97. Apotex Ketorolac Tromethamine Product Table 98. Apotex Recent Developments/Updates Table 99. Sandoz Corporation Information Table 100. Sandoz Description and Business Overview Table 101. Sandoz Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 102. Sandoz Ketorolac Tromethamine Product Table 103. Sandoz Recent Developments/Updates Table 104. Amphastar Pharmaceuticals Corporation Information Table 105. Amphastar Pharmaceuticals Description and Business Overview Table 106. Amphastar Pharmaceuticals Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 107. Amphastar Pharmaceuticals Ketorolac Tromethamine Product Table 108. Amphastar Pharmaceuticals Recent Developments/Updates Table 109. Gland Pharma Limited Corporation Information Table 110. Gland Pharma Limited Description and Business Overview Table 111. Gland Pharma Limited Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 112. Gland Pharma Limited Ketorolac Tromethamine Product Table 113. Gland Pharma Limited Recent Developments/Updates Table 114. Akorn Corporation Information Table 115. Akorn Description and Business Overview Table 116. Akorn Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 117. Akorn Ketorolac Tromethamine Product Table 118. Akorn Recent Developments/Updates Table 119. Sun Pharmaceutical Corporation Information Table 120. Sun Pharmaceutical Description and Business Overview Table 121. Sun Pharmaceutical Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 122. Sun Pharmaceutical Ketorolac Tromethamine Product Table 123. Sun Pharmaceutical Recent Developments/Updates Table 124. Sagent Pharmaceuticals Corporation Information Table 125. Sagent Pharmaceuticals Description and Business Overview Table 126. Sagent Pharmaceuticals Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 127. Sagent Pharmaceuticals Ketorolac Tromethamine Product Table 128. Sagent Pharmaceuticals Recent Developments/Updates Table 129. Aurobindo Pharma Corporation Information Table 130. Aurobindo Pharma Description and Business Overview Table 131. Aurobindo Pharma Ketorolac Tromethamine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022) Table 132. Aurobindo Pharma Ketorolac Tromethamine Product Table 133. Aurobindo Pharma Recent Developments/Updates Table 134. Production Base and Market Concentration Rate of Raw Material Table 135. Key Suppliers of Raw Materials Table 136. Ketorolac Tromethamine Distributors List Table 137. Ketorolac Tromethamine Customers List Table 138. Ketorolac Tromethamine Market Trends Table 139. Ketorolac Tromethamine Market Drivers Table 140. Ketorolac Tromethamine Market Challenges Table 141. Ketorolac Tromethamine Market Restraints Table 142. Global Ketorolac Tromethamine Sales Forecast by Type (2023-2028) & (K Units) Table 143. Global Ketorolac Tromethamine Sales Market Share Forecast by Type (2023-2028) Table 144. Global Ketorolac Tromethamine Revenue Forecast by Type (2023-2028) & (US$ Million) Table 145. Global Ketorolac Tromethamine Revenue Market Share Forecast by Type (2023-2028) Table 146. Global Ketorolac Tromethamine Sales Forecast by Application (2023-2028) & (K Units) Table 147. Global Ketorolac Tromethamine Sales Market Share Forecast by Application (2023-2028) Table 148. Global Ketorolac Tromethamine Revenue Forecast by Application (2023-2028) & (US$ Million) Table 149. Global Ketorolac Tromethamine Revenue Market Share Forecast by Application (2023-2028) Table 150. Global Ketorolac Tromethamine Sales Forecast by Region (2023-2028) & (K Units) Table 151. Global Ketorolac Tromethamine Sales Market Share Forecast by Region (2023-2028) Table 152. Global Ketorolac Tromethamine Revenue Forecast by Region (2023-2028) & (US$ Million) Table 153. Global Ketorolac Tromethamine Revenue Market Share Forecast by Region (2023-2028) Table 154. Research Programs/Design for This Report Table 155. Key Data Information from Secondary Sources Table 156. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Ketorolac Tromethamine Figure 2. Global Ketorolac Tromethamine Market Share by Type in 2021 & 2028 Figure 3. Injection Product Picture Figure 4. Ophthalmic Product Picture Figure 5. Nasal Product Picture Figure 6. Oral tablet Product Picture Figure 7. Global Ketorolac Tromethamine Market Share by Application in 2021 & 2028 Figure 8. Short-term treatment of pain Figure 9. Ophthalmic Surgery Figure 10. Global Ketorolac Tromethamine Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 11. Global Ketorolac Tromethamine Market Size (2017-2028) & (US$ Million) Figure 12. Global Ketorolac Tromethamine Sales (2017-2028) & (K Units) Figure 13. Ketorolac Tromethamine Sales Share by Manufacturers in 2021 Figure 14. Global Ketorolac Tromethamine Revenue Share by Manufacturers in 2021 Figure 15. The Global 5 and 10 Largest Ketorolac Tromethamine Players: Market Share by Revenue in 2021 Figure 16. Ketorolac Tromethamine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 17. Global Ketorolac Tromethamine Sales Market Share by Region (2017-2022) Figure 18. Global Ketorolac Tromethamine Sales Market Share by Region in 2021 Figure 19. Global Ketorolac Tromethamine Revenue Market Share by Region (2017-2022) Figure 20. Global Ketorolac Tromethamine Revenue Market Share by Region in 2021 Figure 21. U.S. Ketorolac Tromethamine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 22. Canada Ketorolac Tromethamine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 23. Germany Ketorolac Tromethamine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 24. France Ketorolac Tromethamine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 25. U.K. Ketorolac Tromethamine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 26. Italy Ketorolac Tromethamine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 27. Russia Ketorolac Tromethamine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 28. China Ketorolac Tromethamine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 29. Japan Ketorolac Tromethamine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 30. South Korea Ketorolac Tromethamine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 31. India Ketorolac Tromethamine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 32. Australia Ketorolac Tromethamine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 33. Taiwan Ketorolac Tromethamine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 34. Indonesia Ketorolac Tromethamine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 35. Thailand Ketorolac Tromethamine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 36. Malaysia Ketorolac Tromethamine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 37. Philippines Ketorolac Tromethamine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 38. Vietnam Ketorolac Tromethamine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 39. Mexico Ketorolac Tromethamine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 40. Brazil Ketorolac Tromethamine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 41. Argentina Ketorolac Tromethamine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 42. Turkey Ketorolac Tromethamine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 43. Saudi Arabia Ketorolac Tromethamine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 44. U.A.E Ketorolac Tromethamine Revenue Growth Rate (2017-2022) & (US$ Million) Figure 45. Sales Market Share of Ketorolac Tromethamine by Type (2017-2022) Figure 46. Manufacturing Cost Structure of Ketorolac Tromethamine Figure 47. Manufacturing Process Analysis of Ketorolac Tromethamine Figure 48. Ketorolac Tromethamine Industrial Chain Analysis Figure 49. Channels of Distribution Figure 50. Distributors Profiles Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation Figure 53. Key Executives Interviewed

Pfizer Omeros Corporation Egalet US Inc. Allergan Dr. Reddy’s Laboratories Teva Mylan West Ward Pharmaceuticals Fresenius Kabi Apotex Sandoz Amphastar Pharmaceuticals Gland Pharma Limited Akorn Sun Pharmaceutical Sagent Pharmaceuticals Aurobindo Pharma